Publication: Loss-of-function mutation in thiamine transporter 1 in a family with autosomal dominant diabetes
| dc.contributor.author | Prapaporn Jungtrakoon | en_US |
| dc.contributor.author | Jun Shirakawa | en_US |
| dc.contributor.author | Patinut Buranasupkajorn | en_US |
| dc.contributor.author | Manoj K. Gupta | en_US |
| dc.contributor.author | Dario F. De Jesus | en_US |
| dc.contributor.author | Marcus G. Pezzolesi | en_US |
| dc.contributor.author | Aussara Panya | en_US |
| dc.contributor.author | Timothy Hastings | en_US |
| dc.contributor.author | Chutima Chanprasert | en_US |
| dc.contributor.author | Christine Mendonca | en_US |
| dc.contributor.author | Rohit N. Kulkarni | en_US |
| dc.contributor.author | Alessandro Doria | en_US |
| dc.contributor.other | Chulalongkorn University | en_US |
| dc.contributor.other | University of Utah, School of Medicine | en_US |
| dc.contributor.other | Faculty of Medicine, Siriraj Hospital, Mahidol University | en_US |
| dc.contributor.other | Joslin Diabetes Center | en_US |
| dc.contributor.other | Harvard Medical School | en_US |
| dc.date.accessioned | 2020-01-27T10:39:16Z | |
| dc.date.available | 2020-01-27T10:39:16Z | |
| dc.date.issued | 2019-01-01 | en_US |
| dc.description.abstract | © 2019 by the American Diabetes Association. Solute Carrier Family 19 Member 2 (SLC19A2) encodes thiamine transporter 1 (THTR1), which facilitates thiamine transport across the cell membrane. SLC19A2 homozygous mutations have been described as a cause of thiamine-responsive megaloblastic anemia (TRMA), an autosomal recessive syndrome characterized by megaloblastic anemia, diabetes, and sensorineural deafness. Here we describe a loss-of-function SLC19A2 mutation (c.A1063C: p.Lys355Gln) in a family with earlyonset diabetes and mild TRMA traits transmitted in an autosomal dominant fashion. We show that SLC19A2- deficient b-cells are characterized by impaired thiamine uptake, which is not rescued by overexpression of the p.Lys355Gln mutant protein. We further demonstrate that SLC19A2 deficit causes impaired insulin secretion in conjunction with mitochondrial dysfunction, loss of protection against oxidative stress, and cell cycle arrest. These findings link SLC19A2 mutations to autosomal dominant diabetes and suggest a role of SLC19A2 in b-cell function and survival. | en_US |
| dc.identifier.citation | Diabetes. Vol.68, No.5 (2019), 1084-1093 | en_US |
| dc.identifier.doi | 10.2337/db17-0821 | en_US |
| dc.identifier.issn | 1939327X | en_US |
| dc.identifier.issn | 00121797 | en_US |
| dc.identifier.other | 2-s2.0-85065113592 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/52369 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065113592&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Loss-of-function mutation in thiamine transporter 1 in a family with autosomal dominant diabetes | en_US |
| dc.type | Conference Paper | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065113592&origin=inward | en_US |
